48
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Predictors of AIDS-Defining Events Among Advanced Naïve Patients After HAART

, , , , , , , , , , , , , & show all
Pages 112-120 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paola Nasta, Dominique Salmon, Antonella d’Arminio Monforte, Jeanne M. Pimenta, Carlo Cerini, Mariarosaria Giralda, Maria Winnock & Alessandro Cozzi-Lepri. (2016) Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort study. HIV Clinical Trials 17:3, pages 96-108.
Read now
A.I. Abioye, A.I. Soipe, A.A. Salako, M.O. Odesanya, T.A. Okuneye, A.I. Abioye, K.A. Ismail & M.O. Omotayo. (2015) Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts. AIDS Care 27:12, pages 1468-1486.
Read now
Laura Waters & Caroline A Sabin. (2011) Late HIV presentation: epidemiology, clinical implications and management. Expert Review of Anti-infective Therapy 9:10, pages 877-889.
Read now

Articles from other publishers (16)

Umer Majeed Khaja, Aashiq Hussain Bhat, Maroof Ahmed, Aarif Ali & Showkat Ahmad Ganie. 2023. Pharmacogenomics. Pharmacogenomics 247 269 .
Zekarias Gessesse Arefaine, Sintayehu Abebe, Ephrem Bekele, Amir Adem, Yohannes Adama, Norbert H. Brockmeyer, Judith Coenenberg, Anja Potthoff & Teferi Gebru Gebremeskel. (2020) Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study. PLOS ONE 15:4, pages e0229757.
Crossref
Carlo Torti, Elena Raffetti, Francesco Donato, Francesco Castelli, Franco Maggiolo, Gioacchino Angarano, Francesco Mazzotta, Andrea Gori, Laura Sighinolfi, Angelo Pan, Roberto Cauda, Alfredo Scalzini, Eugenia Quiros-Roldan, Paola Nasta, Giampietro Gregis, Simone Benatti, Simona Digiambenedetto, Nicoletta Ladisa, Mariarosaria Giralda, Annalisa Saracino, Filippo Castelnuovo, Massimo Di Pietro, Sergio Lo Caputo, Giuseppe Lapadula, Silvia Costarelli, Silvia Lorenzotti, Nicola Mazzini, Giuseppe Paraninfo, Salvatore Casari, Emanuele Focà, Chiara Pezzoli, Massimiliano Fabbiani, Laura Monno, Piera Pierotti, Claudio Ble, Sebastiano Leone, Maria Concetta Postorino, Chiara Fornabaio, Fabio Zacchi, Alessia Zoncada & Giampiero Carosi. (2015) Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). International Journal of Epidemiology, pages dyv192.
Crossref
Giuseppe Lapadula, Liliane Chatenoud, Andrea Gori, Francesco Castelli, Simona Di Giambenedetto, Massimiliano Fabbiani, Franco Maggiolo, Emanuele Focà, Nicoletta Ladisa, Laura Sighinolfi, Massimo Di Pietro, Angelo Pan & Carlo Torti. (2015) Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART. PLOS ONE 10:5, pages e0124741.
Crossref
Jessica L. CastilhoVlada V. MelekhinTimothy R. Sterling. (2014) Sex Differences in HIV Outcomes in the Highly Active Antiretroviral Therapy Era: A Systematic Review. AIDS Research and Human Retroviruses 30:5, pages 446-456.
Crossref
Wen-Hsin Chang, Jung-Hao Wang, Wei-Shuo Ling, Lie Cheng, Chih-Hung Wang, Shainn-Wei Wang & Gwo-Bin Lee. (2013) An intergated microfluidic system for detecting human immunodeficiency virus in blood samples. An intergated microfluidic system for detecting human immunodeficiency virus in blood samples.
Shailendra Dwivedi, Suraj Singh Yadav, Manish Kumar Singh, Shailja Shukla, Sanjay Khattri & Kamlesh Kumar Pant. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine 637 676 .
Amanda Mocroft, Wendy P Bannister, Ole Kirk, Justyna D Kowalska, Peter Reiss, Antonella D'Arminio-Monforte, Jose Gatell, Martin Fisher, Hanna Trocha, Aza Rakhmanova & Jens D Lundgren. (2012) The Clinical Benefits of Antiretroviral Therapy in Severely Immunocompromised HIV-1-Infected Patients with and without Complete Viral Suppression. Antiviral Therapy 17:7, pages 1291-1300.
Crossref
Abbas Rezaianzadeh, Jafar Hasanzadeh, Abbas Alipour, Mohamed Ali Davarpanah, Abdorreza Rajaeifard & Seyed Hamid Reza Tabatabaee. (2012) Impact of Hepatitis C on Survival of HIV-Infected Individuals in Shiraz; South of Iran. Hepatitis Monthly 12:2, pages 106-111.
Crossref
Sanela Martić, Mahmoud Labib & Heinz-Bernhard Kraatz. (2011) On chip electrochemical detection of sarcoma protein kinase and HIV-1 reverse transcriptase. Talanta 85:5, pages 2430-2436.
Crossref
Mahmoud Labib, Sanela Martić, Patrick O. Shipman & Heinz-Bernhard Kraatz. (2011) Electrochemical analysis of HIV-1 reverse transcriptase serum level: Exploiting protein binding to a functionalized nanostructured surface. Talanta 85:1, pages 770-778.
Crossref
Mahmoud Labib, Patrick O. Shipman, Sanela Martić & Heinz-Bernhard Kraatz. (2011) A bioorganometallic approach for rapid electrochemical analysis of human immunodeficiency virus type-1 reverse transcriptase in serum. Electrochimica Acta 56:14, pages 5122-5128.
Crossref
Mahmoud Labib, Patrick O. Shipman, Sanela Martić & Heinz-Bernhard Kraatz. (2011) Towards an early diagnosis of HIV infection: an electrochemical approach for detection ofHIV-1 reverse transcriptase enzyme. The Analyst 136:4, pages 708-715.
Crossref
Marlene Smurzynski, Kunling Wu, Constance A Benson, Ronald J Bosch, Ann C Collier & Susan L Koletar. (2010) Relationship Between CD4+ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:1, pages 117-127.
Crossref
Sara S Dias, Valeska Andreozzi, Maria O Martins & Jorge Torgal. (2009) Predictors of mortality in HIV-associated hospitalizations in Portugal: a hierarchical survival model. BMC Health Services Research 9:1.
Crossref
L. Xiao, J. Zhang, Y.F. Yin, C.L. Chen, Kai Li, A. Chang & P. Sirois. (2008) Molecular diagnosis of HIV and relevant novel technologies in mutation analysis. Biotechnology Advances 26:5, pages 389-397.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.